secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bausch & Lomb Corp (BLCO)
CIK:        0001860742
Form:       8-K
Filed at:   2022-07-20T23:59:59+00:00
Accession:  0001193125-22-197382
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bausch + Lomb begins CEO search; Papa steps down as chair, reaffirms FY2022 guidance
--------------------------------------------------------------------------------

- Joseph Papa steps down as Board chair; Thomas W. Ross Sr. appointed chair. Papa remains CEO until successor found.
- Separation agreement provides Papa with 2x base salary + target bonus lump sum, health benefits, and prorated equity vesting.
- Board reconstitutes committees: Sarah Kavanagh chairs Audit, Richard De Schutter chairs Talent/Comp, Ross chairs Nominating/Governance.
- Company reaffirms full-year 2022 guidance (announced June 8, 2022) and spinoff from Bausch Health expected in 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860742/000119312522197382/0001193125-22-197382-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860742/000119312522197382/d330026d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-197382

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer